The size of the global pharmaceutical supply
chain is growing rapidly. With the increase of
outsourcing and offshoring there are now more
players than ever before in the distribution
Ensuring the safe storage and distribution of
temperature sensitive materials remains a
constant challenge for the pharmaceutical
This report looks at the technologies and
strategies the industry is employing to leverage
partnerships and streamline processes in their
supply chains of temperature sensitive
Over the past year Cold Chain IQ and Pharma
IQ conducted individual interviews with over
100 experts from all stages of the
pharmaceutical and medical devices
distribution chain from logistics to quality
assurance, regulators to manufacturers. In this
report we share their daily challenges and how
they are seeking to overcome these.
With an uncertain global economic landscape,
key concerns for professionals included
adhering to regulations, building value into the
supply chain and implement cost-effective
strategies and solutions.
Against this backdrop, Cold Chain IQ set out to
examine the current challenges of operating a
global pharmaceutical temperature controlled
supply chain and where it is heading in 2020,
with the following questions in mind:
• What is the biggest risk in establishing a
• Which BRIC country represents the biggest
• What place does horizontal collaboration
have in the pharmaceutical supply chain?
• What steps are companies taking to improve
service levels in their cold supply chain?
• Where is the most innovation taking place in
the pharmaceutical supply chain?
During 2011Cold Chain IQ conducted several
online surveys with the industry looking at
investment levels in the temperature controlled
supply chain and key challenges faced by
professionals on which many of the findings in
this report are based.
This report also incorporates the findings of the
SCA live polling session conducted with 300+
logistics and QA professionals at IQPC’s 11th
Cool Chain Logistics Europe event.